Literature DB >> 25341348

[The value of CA19-9 and CEA in predicting resectability of hilar cholangiocarcinoma].

Di Zong, Yong Zeng.   

Abstract

OBJECTIVE: To evaluate the predictability of preoperative serum Carbonhydrate antigen (CA19-9) and Carcino-embryonic antigen (CEA) for tumor resectability in the patients with hilar cholangiocarcinoma (HC).
METHODS: One hundred and three HC patients pathologically diagnosed from 2003 to 2012 were divided into radical resection group and palliative treatment group according to their surgical therapy and resection results, and preoperative serum CA19-9 and CEA data was collected and analyzed retrospectively. Receiver operating characteristic (ROC) curve analysis was applied to find the best cut-off point, and the resectability prediction of different detection methods was evaluated.
RESULTS: In the application of ROC analysis, the cut-off point of CA19-9 and CEA were 400 microg/L and 8 microg/L with the largest Youden's index 0. 2345 (AUC = 0.605 +/- 0.057) and 0. 1635 (AUC = 0.631 +/- 0.055) respectively. The ROC-AUC, sensitivity, specificity, negative predictive value and positive predictive value in the combine detection (parallel test) with this new cut-off point were 0.660 +/- 0.054, 62.79%, 65.00%, 56.25% and 83.33% respectively.
CONCLUSION: The HC patients with "CA19-9 < 400 microg/L + CEA < 8 microg/L" may have big opportunity to have radical resection while those with "CA19-9 > or = 400 microg/L or CEA > or = 8 microg/L" may have small opportunity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25341348

Source DB:  PubMed          Journal:  Sichuan Da Xue Xue Bao Yi Xue Ban        ISSN: 1672-173X


  1 in total

1.  Serum albumin predicts survival in patients with hilar cholangiocarcinoma.

Authors:  Abhijeet Waghray; Anastasia Sobotka; Carlos Romero Marrero; Bassam Estfan; Federico Aucejo; K V Narayanan Menon
Journal:  Gastroenterol Rep (Oxf)       Date:  2016-07-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.